Next Article in Journal
Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
Next Article in Special Issue
Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
Previous Article in Journal
Lupus Vasculitis: An Overview
Previous Article in Special Issue
Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
 
 
Article

Article Versions Notes

Biomedicines 2021, 9(11), 1629; https://doi.org/10.3390/biomedicines9111629
Action Date Notes Link
article pdf uploaded. 6 November 2021 09:45 CET Version of Record https://www.mdpi.com/2227-9059/9/11/1629/pdf-vor
article xml file uploaded 9 November 2021 07:29 CET Original file -
article xml uploaded. 9 November 2021 07:29 CET Update https://www.mdpi.com/2227-9059/9/11/1629/xml
article pdf uploaded. 9 November 2021 07:29 CET Updated version of record https://www.mdpi.com/2227-9059/9/11/1629/pdf
article html file updated 9 November 2021 07:30 CET Original file -
article html file updated 30 July 2022 15:14 CEST Update https://www.mdpi.com/2227-9059/9/11/1629/html
Back to TopTop